A 36 years old multigravida who is at 14 weeks gestation is scheduled for an alpha-fetoprotein test. The alpha fetoprotein test is an indicator of:

1. A

   G I defects

2. B

   Renal defects

3. C

   Cardiac anomalies

4. D

   Neural tube defects

Appeared in: BHU NO-2019

Explanation

• Alpha-fetoprotein (AFP) is a major plasma protein produced by the fetal yolk sac and liver during development.
• The maternal serum alpha-fetoprotein (MSAFP) test is a screening tool primarily used to detect fetal anomalies.
• When a fetus has an open neural tube defect (such as spina bifida or anencephaly), the exposed neural tissue allows AFP to leak directly into the amniotic fluid and subsequently into the maternal bloodstream.
• This leakage results in significantly elevated maternal serum AFP levels, making it a key indicator for these conditions.

Why Other Options Were Wrong

• Option A: While some GI defects, specifically ventral wall defects like gastroschisis and omphalocele, can also cause elevated AFP, the test's primary and most common indication is screening for neural tube defects.
• Option B: Renal defects are not the primary target of AFP screening. They are typically identified through ultrasound examinations that assess kidney anatomy and amniotic fluid levels.
• Option C: AFP levels are not used to screen for cardiac anomalies. Fetal heart defects are assessed using specialized ultrasound, known as fetal echocardiography.

Related Visual

Clinical Relevance

• Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Maternal serum alpha-fetoprotein (MSAFP) screening as background academic context rather than a clinical decision trigger.
• It is critical for nurses to educate patients that the MSAFP test is a screening tool, not a diagnostic test. An abnormal result indicates an increased risk and necessitates further evaluation, such as a high-resolution ultrasound and possibly amniocentesis.
• Nurses must ensure that the gestational age is accurately determined before the test, as AFP levels are interpreted based on specific weekly norms. An incorrect gestational age is the most common reason for a false-positive result.
• Patient counseling should include the implications of both high and low AFP levels, preparing them for potential follow-up and reducing anxiety.

How to Approach the Question

• First, identify the key term in the question: 'alpha-fetoprotein test'.
• Recall the primary purpose of this common prenatal screening test, which is a component of the second-trimester maternal serum screen (triple or quad screen).
• Associate the test results (high or low levels) with specific fetal conditions. A helpful mnemonic is: 'High AFP for Openings, Low AFP is Down low'.
• Evaluate the options based on this knowledge. 'Neural tube defects' like spina bifida are the classic example of an 'opening' in the fetus that allows AFP to leak, causing high levels.
• Analyze the other options. GI defects are also 'openings' but are a less common reason for the test. Renal and cardiac defects are typically screened for using different methods (ultrasound).
• Conclude that 'Neural tube defects' is the primary and most significant condition indicated by an AFP test.

Concept Tested & Keywords

• Concept Tested: Maternal serum alpha-fetoprotein (MSAFP) screening
• Stem keywords: alpha-fetoprotein test, 14 weeks gestation, multigravida, indicator
• Lead-in keywords: indicator of
• Clinical cues: 36 years old multigravida: Advanced maternal age increases the risk for chromosomal abnormalities, which are associated with low AFP levels.
• Clinical cues: 14 weeks gestation: This is within the typical screening window for the AFP test (usually 15-20 weeks).

Question ID

Q22SXksJMxOqR4WUbhNwzh

Copy ID

Reference Book

E6 Obstetrics Williams p. 29-48

E6 Midwifery Obstetrics and Gynecology Nursing Sandeep Kaur p. 50-61